Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
JCO Precision Oncology|January 20, 2022
Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast CancerMarko Velimirovic, Dejan Juric, Andrzej Niemierko, et al.
The Oncologist|December 9, 2022
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case SeriesJamie O Brett, Lauren L Ritterhouse, Erik T Newman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast CancerRobert Wesolowski, Hope S Rugo, Jennifer M Specht, et al.
ACS Central Science|May 30, 2019
Defining the S<sub>N</sub>1 Side of Glycosylation Reactions: Stereoselectivity of Glycopyranosyl CationsThomas Hansen, Ludivine Lebedel, Wouter A Remmerswaal, et al.
The Journal of Organic Chemistry|March 30, 2021
Synthetic (<i>N</i>,<i>N</i>-Dimethyl)doxorubicin Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline Anticancer DrugsDennis P A Wander, Sabina Y van der Zanden, Merijn B L Vriends, et al.
Breast Cancer Research : BCR|October 2, 2023
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
<i>FGFR1</i> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR<sup>+</sup>) Breast CancerJoshua Z Drago, Luigi Formisano, Dejan Juric, et al.
Nature Genetics|December 12, 2018
Acquired HER2 mutations in ER<sup>+</sup> metastatic breast cancer confer resistance to estrogen receptor-directed therapiesUtthara Nayar, Ofir Cohen, Christian Kapstad, et al.
JCO Precision Oncology|May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker AnalysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
Pharmacological Reviews|March 27, 2025
Cell cycle dysregulation in cancerAntonino Glaviano, Samarendra K Singh, E Hui Clarissa Lee, et al.
Pageof 9